Study of a Single Dose of Pretomanid Added to an Optimized Background Regimen in Children With Rifampicin-Resistant Tuberculosis
Clinical trial NCT05586230 · COMPLETED
Trial details
- NCT number
- NCT05586230
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-10-03
- Primary completion
- 2026-04-28
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.